Publications by authors named "Allan D Sniderman"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

396,189

Total Likes

13,446

Extended Reach

3,203,937

Social Features

480
P
Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Tamara Glavinovic, George Thanassoulis, Jacqueline de Graaf, Patrick Couture, Robert A Hegele, Allan D Sniderman

J Am Heart Assoc· October 2022

Videos about Article: user user user 7

10 2 28 4

View All Article and Social Media Activity
T
The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering.
Michael J Pencina, Karol M Pencina, Donald Lloyd-Jones, Alberico L Catapano, George Thanassoulis, Allan D Sniderman

September 2020

Videos about Article: user user

2 5 42 2 4

View All Article and Social Media Activity
A
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.
Allan D Sniderman, George Thanassoulis, Tamara Glavinovic, Ann Marie Navar, Michael Pencina, Alberico Catapano, Brian A Ference

December 2019

Videos about Article: user user user 4

7 21 131 4

View All Article and Social Media Activity
A
ApoB.
Allan D Sniderman, Michael Pencina, George Thanassoulis

Circ Res· May 2019

Videos about Article: user user

2 122 2 121 5

View All Article and Social Media Activity
A
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.
Allan D Sniderman, Ken Williams, John H Contois, Howard M Monroe, Matthew J McQueen, Jacqueline de Graaf, Curt D Furberg

Circ Cardiovasc Qual Outcomes· May 2011

Videos about Article: user user

2 13

View All Article and Social Media Activity
M
Myocardial compression and recoil as determinants of coronary blood flow.
Allan D Sniderman, Kevin J Lachapelle, George Thanassoulis

Eur Heart J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US.
Sadiya S Khan, Xiaoning Huang, Chiadi E Ndumele, Roger S Blumenthal, Michael J Pencina, Allan D Sniderman

JAMA Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk.
Daniel Sehayek, Justine Cole, Elias Björnson, John T Wilkins, Martin B Mortensen, Allan D Sniderman

J Clin Lipidol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoB and Lp(a): core measures to assess cardiovascular risk.
Allan D Sniderman, Michael J Pencina, George Thanassoulis

Eur Heart J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations.
Justine Cole, Patrick Couture, André J Tremblay, Allan D Sniderman

J Clin Lipidol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational study.
Karol M Pencina, George Thanassoulis, Michael J Pencina, Peter P Toth, Allan D Sniderman

Cardiovasc Diabetol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction models for ischemic stroke and bleeding in dialysis patients: a systematic review and meta-analysis.
Christoforos K Travlos, Adario Chirgwin-Dasgupta, Emilie Trinh, Allan D Sniderman, Ahsan Alam

Clin Kidney J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study.
Selin Bilgic, Karol M Pencina, Michael J Pencina, Justine Cole, Line Dufresne, Allan D Sniderman

Arterioscler Thromb Vasc Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?
Allan D Sniderman

J Am Coll Cardiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Origins and Previous Applications of Causal-Benefit Models.
Ciaran Kohli-Lynch, George Thanassoulis, Michael Pencina, Daniel Sehayek, Karol Pencina, Allan D Sniderman

JACC Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels.
Ahmed Sayed, Eric D Peterson, Salim S Virani, Allan D Sniderman, Ann Marie Navar

JAMA Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention.
Allan D Sniderman, Line Dufresne, Karol M Pencina, Selin Bilgic, George Thanassoulis

Eur Heart J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoB Is Ready for Prime Time.
Alan T Remaley, Justine Cole, Allan D Sniderman

J Am Coll Cardiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Causal-Benefit Model to Prevent Cardiovascular Events.
Ciaran Kohli-Lynch, George Thanassoulis, Michael Pencina, Daniel Sehayek, Karol Pencina, Allan D Sniderman

JACC Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Atherosclerosis: Causes, Consequences, and the Passage of Time.
Peter P Toth, Allan D Sniderman

JACC Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care.
Selin Bilgic, Allan D Sniderman

Curr Opin Cardiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triglyceride-rich lipoprotein cholesterol and cardiovascular risk.
Selin Bilgic, Alan T Remaley, Allan D Sniderman

Curr Opin Lipidol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Maud Ahmad, Allan D Sniderman, Robert A Hegele

CMAJ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?
Davide De Marco, Karol Pencina, Michael Pencina, Line Dufresne, George Thanassoulis, Allan D Sniderman

J Clin Lipidol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance/discordance between serum apolipoprotein B, low density lipoprotein cholesterol and non-high density lipoprotein cholesterol in NATPOL 2011 participants - An epidemiological perspective.
Bogdan Solnica, Allan D Sniderman, Adam Wyszomirski, Marcin Rutkowski, Krzysztof Chlebus

Int J Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.
John H Contois, Michel R Langlois, Christa Cobbaert, Allan D Sniderman

J Am Heart Assoc· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein B in cardiovascular risk assessment.
Maud Ahmad, Allan D Sniderman, Robert A Hegele

CMAJ· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart Registry.
Elie Akl, Allan D Sniderman

Circulation· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
dal-GenE was negative-not positive except for COVID-19.
Allan D Sniderman

Eur Heart J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein B versus non-high-density lipoprotein cholesterol: contradictory results in the same journal.
Allan D Sniderman

Eur J Prev Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis